- Home
- PLTK vs TRVI Comparison
PLTK vs TRVI Comparison
Compare PLTK & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLTK | TRVI |
|---|---|---|
| Founded | 2010 | 2011 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | PLTK | TRVI |
|---|---|---|
| Price | $2.85 | $10.66 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 12 |
| Target Price | $5.25 | ★ $20.46 |
| AVG Volume (30 Days) | ★ 2.3M | 1.1M |
| Earning Date | 05-07-2026 | 03-17-2026 |
| Dividend Yield | ★ 14.04% | N/A |
| EPS Growth | N/A | ★ 31.91 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,755,400,000.00 | N/A |
| Revenue This Year | $3.07 | N/A |
| Revenue Next Year | $2.43 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 8.08 | N/A |
| 52 Week Low | $2.68 | $4.85 |
| 52 Week High | $5.59 | $14.39 |
Technical Indicators
Market Signals| Indicator | PLTK | TRVI |
|---|---|---|
| Relative Strength Index (RSI) | 41.69 | 40.82 |
| Support Level | N/A | $10.04 |
| Resistance Level | $3.82 | $11.78 |
| Average True Range (ATR) | 0.16 | 0.80 |
| MACD | 0.02 | -0.17 |
| Stochastic Oscillator | 25.00 | 0.52 |
Price Performance
Historical ComparisonAbout PLTK Playtika Holding Corp.
Playtika Holding Corp is engaged in developing mobile games. Some of its games include Board Kings, House of Fun, Poker Heat, Slotomania, and Bingo Blitz. The company has built live game operations services and a proprietary technology platform to support its portfolio of games. It derives revenue from the sale of virtual items associated with online games. Geographically, the group has a business presence in the USA, EMEA, APAC, and Other regions of which key revenue is derived from the USA. It offers both Mobile and Web-based platforms.
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.